Accenture Invests in Ryght AI to Accelerate Clinical Trials with Agentic AI and Digital Twins

What You Should Know:  – Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes “agentic AI” and its proprietary AI Site Twin platform to create dynamic digital replicas of research sites, allowing pharmaceutical companies to optimize site sel...

• Published date: 11-12-2025 03:00 PM